MoneyWorks4Me

Marksans Pharma informs about daily report regarding the equity shares bought back

02 Nov 2022 Evaluate

With reference to the Buyback of equity shares of Re 1 each of the company in terms of Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018 (‘SEBI Buyback Regulations’) through open market using the Stock Exchanges Mechanism (‘Buyback’), Marksans Pharma has submitted the daily report pursuant to Regulation 18 of the SEBI Buyback Regulations regarding the Equity Shares bought back on November 1, 2022.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..